Abstract
The start of the EU-HTA in 2025 requires a framework guiding HTA bodies and manufacturers reliably and efficiently through the process. The necessary guidelines are currently developed by the EUnetHTA 21. Herein, the scoping process is of particular importance as it defines the scientific questions to be addressed in the assessment. Stakeholders (e.g., manufacturers, associations, service providers) are supposed to be involved in the guideline development by means of a public consultation. It is unclear if and how the hereby identified criticism is addressed by the EUnetHTA 21.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
